These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9536974)

  • 1. Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin.
    Huh J; Chen JC; Furman GM; Malki C; King B; Kafie F; Wilson SE
    J Surg Res; 1998 Jan; 74(1):54-8. PubMed ID: 9536974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of biodegradable amikacin microspheres to prevent vascular graft infection.
    Ney AL; Granja JA; Schuster PA; Tsukayama DT; Jacobs DM; Bubrick MP
    J Surg Res; 1994 Dec; 57(6):698-705. PubMed ID: 7996849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of early vascular graft infection using regional antibiotic release.
    Kuehn C; Graf K; Mashaqi B; Pichlmaier M; Heuer W; Hilfiker A; Stiesch M; Chaberny IF; Haverich A
    J Surg Res; 2010 Nov; 164(1):e185-91. PubMed ID: 20828762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-coated ePTFE decreases graft colonization and neointimal hyperplasia.
    Fischer PE; Schroeppel TJ; Fabian TC; deRijk WG; Edwards NM; Magnotti LJ; Doty DH; Croce MA
    J Surg Res; 2009 Oct; 156(2):199-204. PubMed ID: 19481768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
    Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
    Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
    J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig.
    Hernandez-Richter T; Schardey HM; Löhlein F; Heiss MM; Redondo-Müller M; Hammer C; Schildberg FW
    Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):413-8. PubMed ID: 11112458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
    Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term antibiotic suppressive therapy for an infected thoracic aorta graft].
    Berdal JE; Steinbakk M
    Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2260-2. PubMed ID: 14508548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prosthetic vascular conduit in contaminated fields: a new technology to decrease ePTFE infections.
    Fischer PE; Fabian TC; deRijk WG; Edwards NM; DeCuypere M; Landis RM; Barnard DL; Magnotti LJ; Croce MA
    Am Surg; 2008 Jun; 74(6):524-8; discussion 528-9. PubMed ID: 18556995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
    Yasim A; Gul M; Ciralik H; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision.
    Schutte WP; Helmer SD; Salazar L; Smith JL
    Am J Surg; 2007 Mar; 193(3):385-8; discussion 388. PubMed ID: 17320540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of vascular prosthetic infection by a benzalkonium-oxacillin bonded polytetrafluoroethylene graft.
    Greco RS; Harvey RA; Smilow PC; Tesoriero JV
    Surg Gynecol Obstet; 1982 Jul; 155(1):28-32. PubMed ID: 7089831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local treatment of Dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit.
    Sago T; Mori Y; Takagi H; Iwata H; Murase K; Kawamura Y; Hirose H
    J Vasc Surg; 2003 Jan; 37(1):169-74. PubMed ID: 12514596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin.
    Sakaguchi H; Marui A; Hirose K; Nomura T; Arai Y; Bir SC; Huang Y; Esaki J; Tabata Y; Ikeda T; Komeda M
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):25-31. PubMed ID: 18179914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections.
    Bandyk DF; Novotney ML; Johnson BL; Back MR; Roth SR
    J Surg Res; 2001 Jan; 95(1):44-9. PubMed ID: 11120634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.